We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-3.7%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.8B
AUM Growth
-$666M
Cap. Flow
-$96.6M
Cap. Flow %
-0.75%
Top 10 Hldgs %
47.51%
Holding
1,061
New
185
Increased
203
Reduced
432
Closed
239

Sector Composition

Rank Sector Weight
1 Energy 65.14%
2 Financials 7.72%
3 Healthcare 3.44%
4 Consumer Discretionary 3.09%
5 Technology 2.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AU icon
201
AngloGold Ashanti
AU
$40.3B
$2.29M 0.02%
125,175
-285,450
-70% -$5.67M
ORTX
202
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.25M 0.02%
18,916
-939
-5% -$131K
CODI icon
203
Compass Diversified
CODI
$755M
$2.23M 0.02%
113,200
+99,400
+720% +$1.9M
RARX
204
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.22M 0.02%
93,705
+5,160
+6% +$153K
PLD icon
205
Prologis
PLD
$138B
$2.21M 0.02%
25,956
-870
-3% -$72K
GOSS icon
206
Gossamer Bio
GOSS
$66.5M
$2.21M 0.02%
131,421
-6,504
-5% -$129K
DLR icon
207
Digital Realty Trust
DLR
$73.7B
$2.06M 0.02%
15,885
-753
-5% -$91.6K
SPG icon
208
Simon Property Group
SPG
$74.5B
$2.04M 0.02%
13,114
+1,640
+14% +$255K
FATE icon
209
Fate Therapeutics
FATE
$281M
$2.02M 0.02%
130,386
-6,048
-4% -$116K
EXPE icon
210
Expedia Group
EXPE
$31.2B
$2.01M 0.02%
14,967
+1,027
+7% +$136K
SA
211
Seabridge Gold
SA
$2.8B
$1.99M 0.02%
156,869
+38,034
+32% +$541K
DRNA
212
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.96M 0.02%
136,304
-6,696
-5% -$95.7K
TMO icon
213
Thermo Fisher Scientific
TMO
$211B
$1.93M 0.02%
6,623
+972
+17% +$278K
ANAB icon
214
AnaptysBio
ANAB
$1.6B
$1.89M 0.01%
53,927
-2,636
-5% -$125K
EPZM
215
DELISTED
Epizyme, Inc
EPZM
$1.87M 0.01%
181,550
-8,575
-5% -$108K
PSA icon
216
Public Storage
PSA
$60.2B
$1.85M 0.01%
7,547
-210
-3% -$52.7K
AMGN icon
217
Amgen
AMGN
$203B
$1.85M 0.01%
9,553
-3,964
-29% -$761K
WELL icon
218
Welltower
WELL
$178B
$1.84M 0.01%
20,294
+310
+2% +$27K
INFY icon
219
Infosys
INFY
$45B
$1.82M 0.01%
160,450
-5,504
-3% -$62K
ROP icon
220
Roper Technologies
ROP
$36.3B
$1.8M 0.01%
5,063
-1,789
-26% -$650K
SPGI icon
221
S&P Global
SPGI
$126B
$1.78M 0.01%
7,255
-683
-9% -$171K
YMAB
222
DELISTED
Y-mAbs Therapeutics
YMAB
$1.78M 0.01%
68,175
-3,400
-5% -$86.9K
MUX icon
223
McEwen Inc
MUX
$1.03B
$1.77M 0.01%
113,232
-42,863
-27% -$780K
PSX icon
224
Phillips 66
PSX
$82.9B
$1.76M 0.01%
17,150
-2,810
-14% -$282K
INTC icon
225
Intel
INTC
$466B
$1.74M 0.01%
33,662
+11,777
+54% +$579K

Similar funds

ALPS Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, ALPS Advisors held 1,061 positions worth $12.8B, down 4.9% from $13.5B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors's Q3 2019 filing shows 185 new, 203 increased, 432 reduced and 239 closed positions. Its largest new stake was Newmont: 667,017 shares worth $25.3M. The largest sale was Buckeye Partners, L.P., an estimated $549M.

By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 65% a quarter earlier, followed by Financials and Healthcare.

  • ALPS Advisors's largest Q3 2019 buy was Newmont: 667,017 shares worth $25.3M.
  • ALPS Advisors added most to Western Midstream Partners in Q3 2019, an estimated $178M increase.
  • ALPS Advisors's biggest Q3 2019 reduction was Holly Energy Partners, L.P., cutting an estimated $109M.
  • ALPS Advisors fully exited Buckeye Partners, L.P. in Q3 2019, selling an estimated $549M.
  • ALPS Advisors's ten largest holdings make up 48% of its $12.8B portfolio in Q3 2019.
  • ALPS Advisors opened 185 new positions and closed 239 in Q3 2019.
  • ALPS Advisors's portfolio value fell 4.9% quarter-over-quarter to $12.8B.

Based on ALPS Advisors's 13F filing for Q3 2019, filed 4 Nov 2019.